LONDON--(BUSINESS WIRE)--The POC haematology diagnostics market is poised to grow by USD 1.33 billion during 2020-2024, progressing at a CAGR of over 10% during the forecast period.
Worried about the impact of COVID-19 on your Business? Here is an Exclusive report talking about Market scenarios, Estimates, the impact of lockdown, and Customer Behaviour.
Get FREE Sample Report in Minutes!
The report on the POC haematology diagnostics market provides a holistic update, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis.
The report offers an up-to-date analysis regarding the current global market scenario and the overall market environment. The market is driven by the increasing prevalence of blood disorders and infectious diseases.
The POC haematology diagnostics market analysis includes the product and geography landscape. This study identifies the increasing growth in product launches as one of the prime reasons driving the POC haematology diagnostics market growth during the next few years.
This report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters.
The POC haematology diagnostics market covers the following areas:
POC Haematology Diagnostics Market Sizing
POC Haematology Diagnostics Market Forecast
POC Haematology Diagnostics Market Analysis
Companies Mentioned
- Abbott Laboratories
- Danaher Corp.
- Drucker Diagnostics Inc.
- EKF Diagnostics Holdings Plc
- F. Hoffmann-La Roche Ltd.
- Nihon Kohden Corp.
- Nova Biomedical Corp.
- Shenzhen Mindray Bio-Medical Electronics Co. Ltd.
- Siemens Healthineers AG
-
Sysmex Corp.
Related Reports on Health Care Include:
Global Point of Care Diagnostics Market - Global point of care diagnostics market is segmented by product (hematology diagnostics, infectious disease diagnostics, rapid cardiovascular diagnostics, rapid coagulation diagnostics, and others), end-user (hospitals and clinics, homecare settings, and clinical diagnostic laboratories), and geography (North America, Europe, Asia, and ROW). Click Here to Get an Exclusive Free Sample Report
Global Critical Care Diagnostics Market - Global critical care diagnostics market is segmented by application (microbial and infectious disease testing, hematology testing, cardiac and lipid testing, coagulation testing, and others), end-user (emergency care units, operating rooms, and ICUs), and geography (Asia, Europe, North America, and ROW). Click Here to Get an Exclusive Free Sample Report
Key Topics Covered:
Executive Summary
Market Landscape
- Market ecosystem
- Market characteristics
- Value chain analysis
Market Sizing
- Market definition
- Market segment analysis
- Market size 2019
- Market outlook: Forecast for 2019 - 2024
Five Forces Analysis
- Five Forces summary
- Bargaining power of buyers
- Bargaining power of suppliers
- Threat of new entrants
- Threat of substitutes
- Threat of rivalry
- Market condition
Market Segmentation by Product
- Market segments
- Comparison by Product
- Consumables - Market size and forecast 2019-2024
- Systems - Market size and forecast 2019-2024
- Market opportunity by Product
Customer landscape
Geographic Landscape
- Geographic segmentation
- Geographic comparison
- North America - Market size and forecast 2019-2024
- Europe - Market size and forecast 2019-2024
- Asia - Market size and forecast 2019-2024
- ROW - Market size and forecast 2019-2024
- Key leading countries
- Market opportunity by geography
- Market drivers
- Market challenges
- Market trends
Vendor Landscape
- Vendor landscape
- Landscape disruption
- Competitive scenario
Vendor Analysis
- Vendors covered
- Market positioning of vendors
- Abbott Laboratories
- Danaher Corp.
- Drucker Diagnostics Inc.
- EKF Diagnostics Holdings Plc
- F. Hoffmann-La Roche Ltd.
- Nihon Kohden Corp.
- Nova Biomedical Corp.
- Shenzhen Mindray Bio-Medical Electronics Co. Ltd.
- Siemens Healthineers AG
- Sysmex Corp.
Appendix
- Scope of the report
- Currency conversion rates for US$
- Research methodology
- List of abbreviations
Technavio suggests three forecast scenarios (optimistic, probable, and pessimistic) considering the impact of COVID-19. Technavio’s in-depth research has direct and indirect COVID-19 impacted market research reports.
Register for a free trial today and gain instant access to 17,000+ market research reports.
Technavio's SUBSCRIPTION platform
About Us
Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio’s report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
